Market Research Report

Ophthalmology Therapeutics Market to 2018 - Dosing Convenience and Cost-effectiveness Continue to Drive Eylea's Prescription Share in Wet Age-Related Macular Degeneration (Wet-AMD)
Ophthalmology Therapeutics Market to 2018 - Dosing Convenience and Cost-effectiveness Continue to Drive Eylea's Prescription Share in Wet Age-Related Macular Degeneration (Wet-AMD) Published by GBI Research
Published Product code 216700
Content info Pages: 111
Price

Introduction

Abstract

The global Diabetic Macular Edema (DME) market will expand massively in the near future as a result of lifestyle changes and the introduction of more effective (and more expensive) treatments, says the latest report from pharmaceutical industry experts GBI Research.

According to their new research*, the business intelligence providers expect the global DME market to climb exponentially in value, from $43m in 2011 to a far greater $985m in 2018, exhibiting a Compound Annual Growth Rate (CAGR) of 57%.

Such dramatic growth is primarily attributed to the entrance of key treatments, including Novartis's Lucentis, which gained approval from the European Commission early last year and the US Food and Drug Administration (FDA) this year.

These approval decisions were backed by data from two Novartis-funded clinical trials, RESTORE and RESOLVE, that demonstrated that Lucentis was superior in visual acuity gain versus sham (dummy therapy) or laser therapy - the current standard of care.

Global DME market growth is predicted to be further supported by Alimera's Iluvien and Allergan's Ozurdex. The former gained European approval in June, and will be available for commercial launch by the end of the year, but was rejected by the FDA late last year over safety concerns. Ozurdex, a promising biodegradable implant, is expected to receive FDA approval in 2015.

The global ophthalmology market as a whole is expected to perform far less impressively than its DME portion, primarily due to the impending patent expiries of prostaglandin analogs used in the treatment of glaucoma.

Global industry revenue will climb, however modestly, from $10 billion in 2011 to $12 billion in 2018, at a CAGR of 2.8%.

*Ophthalmology Therapeutics Market to 2018 - Dosing Convenience and Cost-effectiveness Continue to Drive Eylea's Prescription Share in Wet Age-Related Macular Degeneration (Wet-AMD).

This report provides insights into the global ophthalmology therapeutics market, with forecasts until 2018.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GBI Research's team of industry experts.

Table of Contents

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Global Ophthalmology Therapeutics Market - Introduction

  • 2.1. Overview

3. Global Ophthalmology Therapeutics Market - Market Overview

  • 3.1. Introduction
  • 3.2. Revenue
  • 3.3. Annual Cost of Treatment
  • 3.4. Treatment Usage Pattern
  • 3.5. Branded and Generic Market Share

4. Global Ophthalmology Therapeutics Market - Geographical Landscape

  • 4.1. Geographical Break-up
    • 4.1.1. The US
    • 4.1.2. Top Five Countries in Europe
    • 4.1.3. Japan

5. Global Ophthalmology Therapeutics Market - Therapeutic Landscape

  • 5.1. Glaucoma Therapeutics Market
    • 5.1.1. Introduction
    • 5.1.2. Revenue
    • 5.1.3. Annual Cost of Treatment
    • 5.1.4. Treatment Usage Pattern
    • 5.1.5. Treatment Flow Algorithm
    • 5.1.6. Branded and Generic Market Share
    • 5.1.7. Drivers for the Glaucoma Therapeutics Market
    • 5.1.8. Restraints for Glaucoma Therapeutics Market
    • 5.1.9. Geographical Segmentation
  • 5.2. Allergic Conjunctivitis Therapeutics Market
    • 5.2.1. Introduction
    • 5.2.2. Revenue
    • 5.2.3. Annual Cost of Treatment
    • 5.2.4. Treatment Usage Pattern
    • 5.2.5. Treatment Flow Algorithm
    • 5.2.6. Branded and Generic Market Share
    • 5.2.7. Geographical Segmentation
  • 5.3. Wet Age Macular Degeneration Therapeutics Market
    • 5.3.1. Introduction
    • 5.3.2. Revenue
    • 5.3.3. Annual Cost of Treatment
    • 5.3.4. Treatment Usage Pattern
    • 5.3.5. Treatment Flow Algorithm
    • 5.3.6. Branded and Generic Market Share
    • 5.3.7. Drivers for Wet Age-related Macular Degeneration Therapeutics Market
    • 5.3.8. Restraints for Wet Age-Related Macular Degeneration Therapeutics Market
    • 5.3.9. Geographical Segmentation
  • 5.4. Diabetic Macular Edema Therapeutics Market
    • 5.4.1. Introduction
    • 5.4.2. Revenue
    • 5.4.3. Annual Cost of Treatment
    • 5.4.4. Treatment Usage Pattern
    • 5.4.5. Treatment Flow Algorithm
    • 5.4.6. Drivers for Diabetic Macular Edema Therapeutics Market
    • 5.4.7. Restraints for Diabetic Macular Edema Therapeutics Market
    • 5.4.8. Geographical Segmentation
  • 5.5. Dry Eye Syndrome, Therapeutics Market
    • 5.5.1. Introduction
    • 5.5.2. Revenue
    • 5.5.3. Annual Cost of Treatment
    • 5.5.4. Treatment Usage Pattern
    • 5.5.5. Treatment Flow Algorithm
    • 5.5.6. Branded and Generic Market Share
    • 5.5.7. Drivers for Dry Eye Syndrome Therapeutics Market
    • 5.5.8. Restraints for Dry Eye Syndrome Therapeutics Market
    • 5.5.9. Geographical Segmentation

6. Global Ophthalmology Therapeutics Market - APAC

  • 6.1. India
    • 6.1.1. Overview
    • 6.1.2. Key Trends
    • 6.1.3. Key Strategies
  • 6.2. China
    • 6.2.1. Overview
    • 6.2.2. Key Trends
    • 6.2.3. Key Strategies
  • 6.3. Australia
    • 6.3.1. Overview
    • 6.3.2. Pricing and Reimbursement

7. Global Ophthalmology Therapeutics Market - Profiles of Promising Pipeline Products

  • 7.1. Iluvien (fluocinolone acetonide)
    • 7.1.1. Overview
    • 7.1.2. Efficacy
    • 7.1.3. Safety
    • 7.1.4. Clinical Study Details
  • 7.2. Rebamipide (OPC-12759E)
    • 7.2.1. Overview
    • 7.2.2. Clinical Details
  • 7.3. Remura (bromfenac)
    • 7.3.1. Overview
    • 7.3.2. Clinical details
  • 7.4. Ozurdex (dexamethasone)
    • 7.4.1. Overview
    • 7.4.2. Clinical Details
  • 7.5. ISTA -Ecabet Sodium
    • 7.5.1. Overview
  • 7.6. Allergan's Androgen Tear
    • 7.6.1. Overview

8. Global Ophthalmology Therapeutics Market - Competitive Landscape

  • 8.1. Allergan, Inc
    • 8.1.1. Business Overview
    • 8.1.2. SWOT
  • 8.2. Merck & Co Inc
    • 8.2.1. Introduction
    • 8.2.2. SWOT
  • 8.3. Novartis AG
    • 8.3.1. Introduction
    • 8.3.2. SWOT
  • 8.4. Pfizer
    • 8.4.1. Business Description
    • 8.4.2. SWOT
  • 8.5. Roche
    • 8.5.1. Introduction
    • 8.5.2. SWOT

9. Global Ophthalmology Therapeutics Market - Strategic Consolidations

  • 9.1. Mergers and Acquisitions
    • 9.1.1. Introduction
    • 9.1.2. Key Mergers and Acquisitions Deals
    • 9.1.3. Segmentation by Geography
    • 9.1.4. Segmentation by Deal Value
  • 9.2. Co-development Deals
    • 9.2.1. Major Co-development Deals
    • 9.2.2. Segmentation by Geography
  • 9.3. Licensing Deals
    • 9.3.1. Major Licensing Deals
    • 9.3.2. Segmentation by Geography
    • 9.3.3. Segmentation by Value

10. Global Ophthalmology Therapeutics Market - Appendix

  • 10.1. Market Definitions
  • 10.2. Abbreviations
  • 10.3. Bibliography
  • 10.4. Research Methodology
    • 10.4.1. Coverage
    • 10.4.2. Secondary Research
    • 10.4.3. Primary Research
  • 10.5. Therapeutic Landscape
    • 10.5.2. Market Size by Geography
  • 10.6. Geographical Landscape
  • 10.7. Pipeline Analysis
  • 10.8. Competitive Landscape
    • 10.8.1. Expert Panel Validation
  • 10.9. Contact Us
  • 10.10. Disclaimer

List of Tables
  • Table 1: Ophthalmology Market, Global, Revenue, ($bn), 2004 - 2011
  • Table 2: Ophthalmology Market, Global, Revenue, ($bn), 2011 - 2018
  • Table 3: Ophthalmology Market, Global, Annual Cost of Treatment, ($), 2004 - 2011
  • Table 4: Ophthalmology Market, Global, Annual Cost of Treatment, ($), 2011 - 2018
  • Table 5: Ophthalmology Market, Global, Treatment Usage Patterns (million), 2004 - 2011
  • Table 6: Ophthalmology Market, Global, Treatment Usage Patterns (million), 2011 - 2018
  • Table 7: Ophthalmology Market, the US, Revenue ($bn), 2004 - 2011
  • Table 8: Ophthalmology Market, the US, Revenue ($bn), 2011 - 2018
  • Table 9: Ophthalmology Market, the US, Annual Cost of Treatment ($), 2004 - 2011
  • Table 10: Ophthalmology Market, the US, Annual Cost of Treatment ($), 2011 - 2018
  • Table 11: Ophthalmology Market, the US, Treatment Usage Pattern (million), 2004 - 2011
  • Table 12: Ophthalmology Market, the US, Treatment Usage Pattern (million), 2011 - 2018
  • Table 13: Ophthalmology Market, Top Five Countries of Europe, Revenue ($m), 2004 - 2011
  • Table 14: Ophthalmology Market, Top Five Countries of Europe, Revenue ($m), 2011 - 2018
  • Table 15: Ophthalmology Market, Top Five Countries of Europe, Annual Cost of Treatment, ($), 2004 - 2011
  • Table 16: Ophthalmology Market, Top Five Countries of Europe, Annual Cost of Treatment ($), 2011 - 2018
  • Table 17: Ophthalmology Market, Top Five Countries of Europe, Treatment Usage Pattern (million), 2004 - 2011
  • Table 18: Ophthalmology Market, Top Five Countries of Europe, Treatment Usage Pattern (million), 2011 - 2018
  • Table 19: Ophthalmology Market, Japan, Revenue ($m), 2004 - 2011
  • Table 20: Ophthalmology Market, Japan, Revenue ($m), 2011 - 2018
  • Table 21: Ophthalmology Market, Japan, Annual Cost of Treatment ($), 2004 - 2011
  • Table 22: Ophthalmology Market, Japan, Annual Cost of Treatment ($), 2011 - 2018
  • Table 23: Ophthalmology Market, Japan, Treatment Usage Pattern (million), 2004 - 2011
  • Table 24: Ophthalmology Market, Japan, Treatment Usage Pattern (million), 2011 - 2018
  • Table 25: Ophthalmology Market to 2018, Major Types of Glaucoma
  • Table 26: Ophthalmology Market to 2018, Mechanism of Action of Key Glaucoma Medications
  • Table 27: Ophthalmology Market to 2018, Global, Glaucoma, Revenue ($bn), 2004 - 2011
  • Table 28: Ophthalmology Market to 2018, Global, Glaucoma, Revenue Forecast ($bn), 2011 - 2018
  • Table 29: Ophthalmology Market to 2018, Global, Glaucoma, Annual Cost of Therapy ($), 2004 - 2011
  • Table 30: Ophthalmology Market to 2018, Global, Glaucoma, Annual Cost of Therapy ($), 2011 - 2018
  • Table 31: Ophthalmology Market to 2018, Global, Glaucoma, Treatment Usage Pattern (million), 2004 - 2011
  • Table 32: Ophthalmology Market to 2018, Global, Glaucoma, Treatment Usage Pattern (million), 2011 - 2018
  • Table 33: Ophthalmology Market to 2018, Global, Glaucoma, Geographical Segmentation of Revenues ($m), 2004 - 2011
  • Table 34: Ophthalmology Market to 2018, Global, Glaucoma, Geographical Segmentation of Revenues ($m), 2011 - 2018
  • Table 35: Ophthalmology Market to 2018, Global, Allergic Conjunctivitis, Revenue ($m), 2004 - 2011
  • Table 36: Ophthalmology Market to 2018, Global, Allergic Conjunctivitis, Revenue ($m), 2011 - 2018
  • Table 37: Ophthalmology Market to 2018, Global, Allergic Conjunctivitis, Annual Cost of Therapy ($), 2004 - 2011
  • Table 38: Ophthalmology Market to 2018, Global, Allergic Conjunctivitis, Annual Cost of Therapy ($), 2011 - 2018
  • Table 39: Ophthalmology Market to 2018, Global, Allergic Conjunctivitis, Treatment Usage Pattern (million), 2004 - 2011
  • Table 40: Ophthalmology Market to 2018, Global, Allergic Conjunctivitis, Treatment Usage Pattern (million), 2011 - 2018
  • Table 41: Ophthalmology Market to 2018, Global, Allergic Conjunctivitis, Geographical Segmentation of Revenues ($m), 2004 - 2011
  • Table 42: Ophthalmology Market to 2018, Global, Allergic Conjunctivitis, Geographical Segmentation of Revenues ($m), 2011 - 2018
  • Table 43: Ophthalmology Market to 2018, Global, Wet Age Related Macular Degeneration, Revenue ($bn), 2004 - 2011
  • Table 44: Ophthalmology Market to 2018, Global, Wet Age Related Macular Degeneration, Revenue ($bn), 2011 - 2018
  • Table 45: Ophthalmology Market to 2018, Global, Wet Age Related Macular Degeneration, ACT ($), 2004 - 2011
  • Table 46: Ophthalmology Market to 2018, Global, Wet Age Related Macular Degeneration, ACT ($), 2011 - 2018
  • Table 47: Ophthalmology Market to 2018, Global, Wet-Age Related Macular Degeneration, Treatment Usage Pattern (million), 2004 - 2011
  • Table 48: Ophthalmology Market to 2018, Global, Wet-Age Related Macular Degeneration, Treatment Usage Pattern (million), 2011 - 2018
  • Table 49: Ophthalmology Market to 2018, Global, Wet Age-Related Macular Degeneration, Geographical Segmentation of Revenues ($m), 2004 - 2011
  • Table 50: Ophthalmology Market to 2018, Global, Wet Age-Related Macular Degeneration, Geographical Segmentation of Revenues ($m), 2011 - 2018
  • Table 51: Ophthalmology Market to 2018, Global, Diabetic Macular Edema, Revenue ($m), 2011 - 2018
  • Table 52: Ophthalmology Market to 2018, Global, Diabetic Macular Edema, Annual Cost of Therapy ($), 2011 - 2018
  • Table 53: Ophthalmology Market to 2018, Global, Diabetic Macular Edema, Treatment Usage Pattern (‘000), 2011 - 2018
  • Table 54: Ophthalmology Market to 2018, Global, Diabetic Macular Edema, Geographical Segmentation of Revenues ($m), 2011 - 2018
  • Table 55: Ophthalmology Market to 2018, Global, Dry Eye Syndrome, Revenue ($bn), 2004 - 2011
  • Table 56: Ophthalmology Market to 2018, Global, Dry Eye Syndrome, Revenue ($bn), 2011 - 2018
  • Table 57: Ophthalmology Market to 2018, Global, Dry Eye Syndrome, Annual Cost of Therapy ($), 2004 - 2011
  • Table 58: Ophthalmology Market to 2018, Global, Dry Eye Syndrome, Annual Cost of Therapy ($), 2011 - 2018
  • Table 59: Ophthalmology Market to 2018, Global, Dry Eye Syndrome, Treatment Usage Pattern (million), 2004 - 2011
  • Table 60: Ophthalmology Market to 2018, Global, Dry Eye Syndrome, Treatment Usage Pattern (million), 2011 - 2018
  • Table 61: Ophthalmology Market to 2018, Global, Dry Eye Syndrome, Geographical Segmentation of Revenues ($m), 2004 - 2011
  • Table 62: Ophthalmology Market to 2018, Global, Dry Eye Syndrome, Geographical Segmentation of Revenues ($m), 2011 - 2018
  • Table 63: Ophthalmology Market to 2018, PBS Reimbursement List, Australia, 2012
  • Table 64: Ophthalmology Market to 2018, Global, Number of Deals by Geography, 2009 - 2012
  • Table 65: Ophthalmology Market to 2018, Global, Number of Deals by Deal Value ($m), 2009 - 2012
  • Table 66: Ophthalmology Market to 2018, Global, Number of Deals by Geography, 2009 - 2012
  • Table 67: Ophthalmology Market to 2018, Global, Number of Deals by Geography, 2009 - 2012
  • Table 68: Ophthalmology Market to 2018, Global, Number of Deals by Deal Value ($m), 2009 - 2012

List of Figures
  • Figure 1: Ophthalmology Market to 2018, Global, Revenue, ($bn), 2004 - 2018
  • Figure 2: Ophthalmology Market to 2018, Global, Annual Cost of Treatment, ($), 2004 - 2018
  • Figure 3: Ophthalmology Market, Global, Treatment Usage Patterns (million), 2004 - 2018
  • Figure 4: Ophthalmology Market to 2018, Global, Branded and Generic Market Share (%), 2011 and 2018
  • Figure 5: Ophthalmology Market, the US, Revenue ($bn), 2004 - 2018
  • Figure 6: Ophthalmology Market, the US, Annual Cost of Treatment ($), 2004 - 2018
  • Figure 7: Ophthalmology Market, the US, Treatment Usage Pattern (million), 2004 - 2018
  • Figure 8: Ophthalmology Market, Top Five Countries of Europe, Revenue ($m), 2004 - 2018
  • Figure 9: Ophthalmology Market, Top Five Countries of Europe, Annual Cost of Treatment ($), 2004 - 2018
  • Figure 10: Ophthalmology Market, Top Five Countries of Europe, Treatment Usage Pattern (million), 2004 - 2018
  • Figure 11: Ophthalmology Market, Japan, Revenue ($m), 2004 - 2018
  • Figure 12: Ophthalmology Market, Japan, Annual Cost of Treatment ($), 2004 - 2018
  • Figure 13: Ophthalmology Market, Japan, Treatment Usage Pattern (million), 2004 - 2018
  • Figure 14: Ophthalmology Market to 2018, Global, Glaucoma, Revenue ($bn), 2004 - 2018
  • Figure 15: Ophthalmology Market to 2018, Global, Glaucoma, Annual Cost of Therapy ($), 2004 - 2018
  • Figure 16: Ophthalmology Market to 2018, Global, Glaucoma, Treatment Usage Pattern (million), 2004 - 2018
  • Figure 17: Ophthalmology Market to 2018, Glaucoma, Treatment Flow Algorithm
  • Figure 18: Ophthalmology Market to 2018, Glaucoma Market, Global, Branded and Generic Market Share (%), 2011 and 2018
  • Figure 19: Ophthalmology Market to 2018, Global, Glaucoma, Geographical Segmentation of Revenues ($m), 2004 - 2018
  • Figure 20: Ophthalmology Market to 2018, Global, Allergic Conjunctivitis, Revenue ($m), 2004 - 2018
  • Figure 21: Ophthalmology Market to 2018, Global, Allergic Conjunctivitis, Annual Cost of Therapy ($), 2004 - 2018
  • Figure 22: Ophthalmology Market to 2018, Global, Allergic Conjunctivitis, Treatment Usage Pattern (million), 2004 - 2018
  • Figure 23: Ophthalmology Market to 2018, Allergic Conjunctivitis, Global, Treatment Flow Algorithm
  • Figure 24: Ophthalmology Market to 2018, Branded and Generic Market Share (%), 2011 and 2018
  • Figure 25: Ophthalmology Market to 2018, Global, Allergic Conjunctivitis, Geographical Segmentation of Revenues ($m), 2004 - 2018
  • Figure 26: Ophthalmology Market to 2018, Global, Wet Age Related Macular Degeneration, Revenue ($bn), 2004 - 2018
  • Figure 27: Ophthalmology Market to 2018, Global, Wet Age Related Macular Degeneration, ACT ($), 2004 - 2018
  • Figure 28: Ophthalmology Market to 2018, Global, Wet Age-Related Macular Degeneration, Treatment Usage Pattern (million), 2004 - 2018
  • Figure 29: Ophthalmology Market to 2018, Wet Age-Related Macular Degeneration, Global, Treatment Flow Algorithm
  • Figure 30: Ophthalmology Market to 2018, Wet-Age Related Macular Degeneration, Global, Branded and Generic Market Share (%), 2011 - 2018
  • Figure 31: Ophthalmology Market to 2018, Global, Wet Age-Related Macular Degeneration, Geographical Segmentation of Revenues ($m), 2004 - 2018
  • Figure 32: Ophthalmology Market to 2018, Global, Diabetic Macular Edema, Revenue ($m), 2011 - 2018
  • Figure 33: Ophthalmology Market to 2018, Global, Diabetic Macular Edema, Annual Cost of Therapy ($), 2011 - 2018
  • Figure 34: Ophthalmology Market to 2018, Global, Diabetic Macular Edema, Treatment Usage Pattern (‘000), 2004 - 2018
  • Figure 35: Ophthalmology Market to 2018, Diabetic Macular Edema, Global, Treatment Flow Algorithm
  • Figure 36: Ophthalmology Market to 2018, Global, Diabetic Macular Edema, Geographical Segmentation of Revenues ($m), 2011 - 2018
  • Figure 37: Ophthalmology Market to 2018, Global, Dry Eye Syndrome, Revenue ($bn), 2004 - 2018
  • Figure 38: Ophthalmology Market to 2018, Global, Dry Eye Syndrome, Annual Cost of Therapy ($), 2004 - 2018
  • Figure 39: Ophthalmology Market to 2018, Global, Dry Eye Syndrome, Treatment Usage Pattern (million), 2004 - 2018
  • Figure 40: Ophthalmology Market to 2018, Dry Eye Syndrome, Global, Treatment Flow Algorithm, 2011
  • Figure 41: Ophthalmology Market to 2018, Dry Eye Syndrome, Global, Branded and Generic Market Share (%), 2011 - 2018
  • Figure 42: Ophthalmology Market to 2018, Global, Dry Eye Syndrome, Geographical Segmentation of Revenues ($m), 2004 - 2018
  • Figure 43: Ophthalmology Market to 2018, Allergan, SWOT, 2012
  • Figure 44: Ophthalmology Market to 2018, Merck Co & Inc, SWOT, 2012
  • Figure 45: Ophthalmology Market to 2018, Novartis AG, SWOT, 2012
  • Figure 46: Ophthalmology Market to 2018, Pfizer, SWOT, 2012
  • Figure 47: Ophthalmology Market to 2018, Roche, SWOT, 2012
  • Figure 48: Ophthalmology Market to 2018, Global, Number of Deals by Geography (%), 2009 - 2012
  • Figure 49: Ophthalmology Market to 2018, Global, Segmentation of Deals by Value (%),2009 - 2012
  • Figure 50: Ophthalmology Market to 2018 Global, Number of Deals by Geography (%),2009 - 2012
  • Figure 51: Ophthalmology Market to 2018, Global, Number of Deals by Geography (%), 2009 - 2012
  • Figure 52: Ophthalmology Market to 2018, Global, Number of Deals by Deal Value (%), 2009 - 2012
  • Figure 53: GBI Research Market Forecasting Model

Ophthalmology Therapeutics Market to 2018 - Dosing Convenience and Cost-effectiveness Continue to Drive Eylea's Prescription Share in Wet Age-Related Macular Degeneration (Wet-AMD) published by GBI Research in October 15, 2012. This report consists of Pages: 111 and the price starts from US $ 3500.

The contents of this page may be different from the latest version. Please contact us for details.
Back to Top